28005982|t|Depot Dependent Effects of Dexamethasone on Gene Expression in Human Omental and Abdominal Subcutaneous Adipose Tissues from Obese Women
28005982|a|Glucocorticoids promote fat accumulation in visceral compared to subcutaneous depots, but the molecular mechanisms involved remain poorly understood. To identify long-term changes in gene expression that are differentially sensitive or responsive to glucocorticoids in these depots, paired samples of human omental (Om) and abdominal subcutaneous (Abdsc) adipose tissues obtained from obese women during elective surgery were cultured with the glucocorticoid receptor agonist dexamethasone (Dex, 0, 1, 10, 25 and 1000 nM) for 7 days. Dex regulated 32% of the 19,741 genes on the array, while 53% differed by Depot and 2.5% exhibited a Depot * Dex concentration interaction. Gene set enrichment analysis showed Dex regulation of the expected metabolic and inflammatory pathways in both depots. Cluster analysis of the 460 transcripts that exhibited an interaction of Depot and Dex concentration revealed sets of mRNAs for which the responses to Dex differed in magnitude, sensitivity or direction between the two depots as well as mRNAs that responded to Dex only in one depot. These transcripts were also clearly depot different in fresh adipose tissue and are implicated in processes that could affect adipose tissue distribution or functions (e.g. adipogenesis, triacylglycerol synthesis and storage, insulin action). Elucidation of the mechanisms underlying the depot differences in the effect of Dex on the expression of specific genes and pathways that regulate adipose function may offer novel insights into understanding the biology of visceral adipose tissues and their links to metabolic health.
28005982	0	5	Depot	T082	C1254362
28005982	27	40	Dexamethasone	T109,T121	C0011777
28005982	44	59	Gene Expression	T045	C0017262
28005982	63	68	Human	T016	C0086418
28005982	69	76	Omental	T023	C0028977
28005982	81	119	Abdominal Subcutaneous Adipose Tissues	T024	C1563741
28005982	125	130	Obese	T047	C0028754
28005982	131	136	Women	T098	C0043210
28005982	137	152	Glucocorticoids	T109,T125	C0017710
28005982	161	164	fat	T201	C0344335
28005982	165	177	accumulation	T033	C4055506
28005982	181	189	visceral	T082	C0442045
28005982	190	198	compared	T052	C1707455
28005982	202	214	subcutaneous	T082	C0443315
28005982	215	221	depots	T082	C1254362
28005982	231	251	molecular mechanisms	T044	C3537153
28005982	309	316	changes	T169	C0392747
28005982	320	335	gene expression	T045	C0017262
28005982	360	369	sensitive	T169	C0332324
28005982	373	383	responsive	T169	C0205342
28005982	387	402	glucocorticoids	T109,T125	C0017710
28005982	412	418	depots	T082	C1254362
28005982	438	443	human	T016	C0086418
28005982	444	451	omental	T023	C0028977
28005982	453	455	Om	T023	C0028977
28005982	461	507	abdominal subcutaneous (Abdsc) adipose tissues	T024	C1563741
28005982	508	516	obtained	T169	C1301820
28005982	522	527	obese	T047	C0028754
28005982	528	533	women	T098	C0043210
28005982	541	557	elective surgery	T061	C0206058
28005982	563	571	cultured	T059	C0040284
28005982	581	604	glucocorticoid receptor	T116,T192	C0034809
28005982	605	612	agonist	T121	C2987634
28005982	613	626	dexamethasone	T109,T121	C0011777
28005982	628	631	Dex	T109,T121	C0011777
28005982	671	674	Dex	T109,T121	C0011777
28005982	703	708	genes	T028	C0017337
28005982	716	721	array	T082	C1510941
28005982	745	750	Depot	T082	C1254362
28005982	772	777	Depot	T082	C1254362
28005982	780	783	Dex	T109,T121	C0011777
28005982	784	797	concentration	T081	C1446561
28005982	798	809	interaction	T169	C1704675
28005982	811	819	Gene set	T028	C0017337
28005982	831	839	analysis	T062	C0936012
28005982	847	850	Dex	T109,T121	C0011777
28005982	851	861	regulation	T038	C1327622
28005982	869	877	expected	T170	C1517001
28005982	878	887	metabolic	T169	C0311400
28005982	892	913	inflammatory pathways	T042	C1512758
28005982	922	928	depots	T082	C1254362
28005982	930	946	Cluster analysis	T062	C0009085
28005982	958	969	transcripts	T114	C1519595
28005982	988	999	interaction	T169	C1704675
28005982	1003	1008	Depot	T082	C1254362
28005982	1013	1016	Dex	T109,T121	C0011777
28005982	1031	1039	revealed	T080	C0443289
28005982	1048	1053	mRNAs	T114,T123	C0035696
28005982	1081	1084	Dex	T109,T121	C0011777
28005982	1097	1106	magnitude	T081	C1704240
28005982	1123	1132	direction	T082	C0449738
28005982	1149	1155	depots	T082	C1254362
28005982	1167	1172	mRNAs	T114,T123	C0035696
28005982	1191	1194	Dex	T109,T121	C0011777
28005982	1207	1212	depot	T082	C1254362
28005982	1220	1231	transcripts	T114	C1519595
28005982	1250	1255	depot	T082	C1254362
28005982	1275	1289	adipose tissue	T024	C0001527
28005982	1312	1321	processes	T067	C1522240
28005982	1340	1354	adipose tissue	T024	C0001527
28005982	1355	1367	distribution	T169	C0220927
28005982	1371	1380	functions	T042	C0232456
28005982	1387	1399	adipogenesis	T044	C0596843
28005982	1401	1426	triacylglycerol synthesis	T044	C1157337
28005982	1431	1438	storage	T043	C1327211
28005982	1440	1454	insulin action	T044	C1145751
28005982	1476	1486	mechanisms	T169	C0441712
28005982	1502	1507	depot	T082	C1254362
28005982	1537	1540	Dex	T109,T121	C0011777
28005982	1548	1558	expression	T045	C0017262
28005982	1571	1576	genes	T028	C0017337
28005982	1595	1603	regulate	T038	C1327622
28005982	1604	1611	adipose	T024	C0001527
28005982	1612	1620	function	T169	C0542341
28005982	1669	1676	biology	T091	C0005532
28005982	1680	1688	visceral	T082	C0442045
28005982	1689	1704	adipose tissues	T024	C0001527
28005982	1724	1733	metabolic	T169	C0311400
28005982	1734	1740	health	T080	C0018759